Metformin + Sitagliptin
Composition
This formulation contain combination of Metformin and Sitagliptin as active agents
Indications
used to treat type 2 diabetes mellitus in adults
Side effects
lactic acidosis and pancreatitis, hypoglycemia, headache, upper respiratory tract infections
Precautions
Use caution in patients with a history of pancreatitis, renal impairment, or heart failure
Contraindications
Contraindications include hypersensitivity as well as diabetic ketoacidosis, severe renal impairment, and heart failure.
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai